Type 2 Diabetes Mellitus and COVID-19: A Narrative Review

Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients.

Automated summary

Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder that is increasing globally and has become epidemic in high- and middle-income countries. There is evidence of a bidirectional interaction between T2DM and COVID-19, with individuals with T2DM having worse prognosis and new cases of T2DM being diagnosed after SARS-CoV-2 infection. Understanding the link between T2DM and COVID-19 can help identify risk factors and develop strategies to improve the prognosis for these patients.